SUPER GROUP SGHC LTD (SGHC)

GG00BMG42V42 - Common Stock

3.48  -0.01 (-0.29%)

After market: 3.48 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SGHC. SGHC was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. While SGHC seems to be doing ok healthwise, there are quite some concerns on its profitability. SGHC is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

SGHC had positive earnings in the past year.

1.2 Ratios

The Return On Assets of SGHC (4.60%) is better than 63.16% of its industry peers.
With a decent Return On Equity value of 8.05%, SGHC is doing good in the industry, outperforming 60.90% of the companies in the same industry.
SGHC has a better Return On Invested Capital (9.26%) than 69.17% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SGHC is significantly above the industry average of 10.07%.
The 3 year average ROIC (45.51%) for SGHC is well above the current ROIC(9.26%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.6%
ROE 8.05%
ROIC 9.26%
ROA(3y)25.23%
ROA(5y)N/A
ROE(3y)97.11%
ROE(5y)N/A
ROIC(3y)45.51%
ROIC(5y)N/A

1.3 Margins

SGHC has a Profit Margin (3.24%) which is in line with its industry peers.
SGHC has a worse Operating Margin (4.68%) than 63.16% of its industry peers.
Industry RankSector Rank
OM 4.68%
PM (TTM) 3.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

SGHC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SGHC has more shares outstanding than it did 1 year ago.
The debt/assets ratio for SGHC has been reduced compared to a year ago.

2.2 Solvency

SGHC has an Altman-Z score of 4.45. This indicates that SGHC is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.45, SGHC belongs to the best of the industry, outperforming 87.97% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that SGHC is not too dependend on debt financing.
The Debt to Equity ratio of SGHC (0.01) is better than 90.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 4.45
ROIC/WACC1.02
WACC9.08%

2.3 Liquidity

SGHC has a Current Ratio of 1.25. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.25, SGHC perfoms like the industry average, outperforming 59.40% of the companies in the same industry.
A Quick Ratio of 1.25 indicates that SGHC should not have too much problems paying its short term obligations.
SGHC's Quick ratio of 1.25 is fine compared to the rest of the industry. SGHC outperforms 65.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25

4

3. Growth

3.1 Past

SGHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.20%.
Looking at the last year, SGHC shows a very negative growth in Revenue. The Revenue has decreased by -38.47% in the last year.
Measured over the past years, SGHC shows a very strong growth in Revenue. The Revenue has been growing by 39.50% on average per year.
EPS 1Y (TTM)-88.2%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-16.67%
Revenue 1Y (TTM)-38.47%
Revenue growth 3Y39.5%
Revenue growth 5YN/A
Revenue growth Q2Q15.95%

3.2 Future

SGHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.09% yearly.
The Revenue is expected to grow by 10.22% on average over the next years. This is quite good.
EPS Next Y-69.69%
EPS Next 2Y-10.69%
EPS Next 3Y7.09%
EPS Next 5YN/A
Revenue Next Year10.73%
Revenue Next 2Y11.82%
Revenue Next 3Y10.22%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 14.50 indicates a correct valuation of SGHC.
SGHC's Price/Earnings ratio is a bit cheaper when compared to the industry. SGHC is cheaper than 78.95% of the companies in the same industry.
SGHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.11.
SGHC is valuated correctly with a Price/Forward Earnings ratio of 12.66.
Based on the Price/Forward Earnings ratio, SGHC is valued cheaper than 80.45% of the companies in the same industry.
SGHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.5
Fwd PE 12.66

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SGHC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.61

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.69%
EPS Next 3Y7.09%

0

5. Dividend

5.1 Amount

SGHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUPER GROUP SGHC LTD

NYSE:SGHC (5/7/2024, 7:22:29 PM)

After market: 3.48 0 (0%)

3.48

-0.01 (-0.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.74B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.5
Fwd PE 12.66
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.6%
ROE 8.05%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.68%
PM (TTM) 3.24%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-88.2%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-69.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-38.47%
Revenue growth 3Y39.5%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y